KISNER DANIEL L - Insider Non-Derivative Transactions at Zynerba Pharmaceuticals, Inc. (ZYNE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 10, 2023, KISNER DANIEL L's relationship to Zynerba Pharmaceuticals, Inc. (ZYNE) is Director, and currently has 47,824 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZYNE insiders.
Data Source: SEC.
KISNER DANIEL L - Insider Non-Derivative Transactions of ZYNE Common Stock
KISNER DANIEL L - Insider Non-Derivative Transactions at ZYNE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 11, 2023 | U -- (Common Stock) | 47824 | 0 | 0 |
| Oct 11, 2023 | U -- (Common Stock) | 27954 | 0 | 47824 |
| Jun 15, 2023 | Sell -- (Common Stock) | 115 | 0.35 | 75778 |
| Jun 14, 2023 | Acquisition -- (Common Stock) | 47824 | 0 | 75893 |